Bleeding risk and incidence in real world percutaneous coronary intervention patients with ticagrelor
To investigate the incidence and severity of bleeding at discharge and 30 days in real world clinical practice with Ticagrelor in patients undergoing PCI.
I. Subiakto, A. Ul Haq, W. Van Gaal
The Northern Hospital, Epping, Sydney, Australia
Heart, Lung and Circulation – Volume 23, Supplement 1, e1-e48
Abstract & full-text available.
Resource Library Item
This resource is available for registered members of CSANZ.
Click the button below to log in to HeartOne and access this resource. Please note that CPD credit is NOT automatically assigned for accessing resources directly.